Search Results - "PAULUSSEN, J. J. C"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    REACH alternative testing strategy for skin sensitization in practice: Fact or fiction? by Barentsen, Helma M., Jonis, Simon U., Pelgrom, Sylvia M.G.J., Rijk, Jeroen C.W., Westerink, Walter M.A., Paulussen, Jeannette J.C.

    Published in Regulatory toxicology and pharmacology (01-08-2019)
    “…From October 2016 the REACH Regulation requires an alternative testing strategy for skin sensitization. The current paper describes our experience when putting…”
    Get full text
    Journal Article
  2. 2

    Inhibition of mediator release in RBL-2H3 cells by some H1-antagonist derived anti-allergic drugs: relation to lipophilicity and membrane effects by Fischer, M J, Paulussen, J J, Horbach, D A, Roelofsen, E P, van Miltenburg, J C, de Mol, N J, Janssen, L H

    Published in Inflammation research (01-02-1995)
    “…In a model for mucosal mast cells (RBL-2H3 cells) a set H1-antagonist derived anti-allergic drugs containing a diphenylmethyl piperazinyl moiety was examined…”
    Get full text
    Journal Article
  3. 3

    Dual effect of the anti-allergic astemizole on Ca2+ fluxes in rat basophilic leukemia (RBL-2H3) cells : Release of Ca2+ from intracellular stores and inhibition of Ca2+ release-activated Ca2+ influx by FISCHER, M. J. E, PAULUSSEN, J. J. C, DE MOL, N. J, JANSSEN, L. H. M

    Published in Biochemical pharmacology (15-04-1998)
    “…The antiallergic drugs astemizole and norastemizole inhibit exocytosis in mast cells, which might be relevant for their therapeutic action. From previous…”
    Get full text
    Journal Article
  4. 4

    Structure-activity relationships of astemizole derivatives for inhibition of store operated Ca2+ channels and exocytosis by FISCHER, M. J. E, PAULUSSEN, J. J. C, TOLLENAERE, J. P, DE MOL, N. J, JANSSEN, L. H. M

    Published in European journal of pharmacology (05-06-1998)
    “…The effects of a series of analogues of the antiallergic drug astemizole on the exocytosis of the enzyme beta-hexosaminidase were studied in a mast cell model,…”
    Get full text
    Journal Article
  5. 5

    Influence of the antiallergic drug oxatomide and derivatives on membrane structures: relation with inhibition of calcium influx in rat basophilic leukemia cells by Paulussen, Jeannette J.C., Fischer, Marcel J.E., Zuidam, Nicolaas J., v. Miltenburg, J.Cees, de Mol, Nico J., Janssen, Lambert H.M.

    Published in Biochemical pharmacology (01-03-1999)
    “…Oxatomide is an H 1 antihistaminic drug that also inhibits mediator release from mast cells. From previous studies, it appeared that inhibition of the influx…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Influence of the anti-allergic drug oxatomide on the signal transduction mechanism in a mast cell model by Paulussen, Jeannette J.C., Fischer, Marcel J.E., Kok-Van Esterik, Jolien A.E., Tiemessen, Radboud C., De Mol, Nico J., Janssen, Lambert H.M.

    Published in European journal of pharmacology (19-09-1996)
    “…In a mast cell model, oxatomide displays inhibition of mediator release which is not related to its histamine H 1 receptor antagonistic activity. From a…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Effects of the anti-allergics astemizole and norastemizole on FcεRI receptor-mediated signal transduction processes by Fischer, Marcel J.E, Paulussen, Jeannette J.C, Kok-Van Esterik, Jolien A.E, Van der Heijden, Vincent S, De Mol, Nico J, Janssen, Lambert H.M

    Published in European journal of pharmacology (12-03-1997)
    “…The non-sedating anti-allergic drug astemizole, apart from its potential to antagonise H 1 receptors, inhibits the release of inflammation mediators from mast…”
    Get full text
    Journal Article